Equity Overview
Price & Market Data
Price: $2.80
Daily Change: -$0.16 / 5.71%
Daily Range: $2.78 - $3.03
Market Cap: $24,074,960
Daily Volume: 73,223
Performance Metrics
1 Week: 12.90%
1 Month: -4.37%
3 Months: 21.74%
6 Months: 6.87%
1 Year: -4.44%
YTD: -6.04%
Company Details
Employees: 26
Sector: Health technology
Industry: Pharmaceuticals: major
Country:
Details
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such as metastatic pancreatic ductal adenocarcinoma, cholangiocarcinoma, appendiceal cancer, and colon cancer and glioblastoma multiforme in combination with a range of anti-cancer regimens. The company was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.